PIK3CA-MUTATED CANCERS

Clinical trials for PIK3CA-MUTATED CANCERS explained in plain language.

Never miss a new study

Get alerted when new PIK3CA-MUTATED CANCERS trials appear

Sign up with your email to follow new studies for PIK3CA-MUTATED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental drug cocktail targets genetic driver in Tough-to-Treat cancers

Disease control Recruiting now

This early-stage study is testing the safety and initial effectiveness of a new drug called inavolisib, both alone and combined with two existing immunotherapy drugs (atezolizumab and pembrolizumab). It's for people with advanced head and neck cancer and other cancers that have a…

Matched conditions: PIK3CA-MUTATED CANCERS

Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

PIK3CA-MUTATED CANCERS

Get alerted when new PIK3CA-MUTATED CANCERS trials appear

Experimental drug cocktail targets genetic driver in Tough-to-Treat cancers